Ibandronate Polymorph B

Patent No. EP1848727 (titled "Ibandronate Polymorph B") was filed by Atnahs Pharma UK on Jan 24, 2006. The application was issued on Jun 17, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXALMar 17, 2016HAMM&WITTKOPP PATENTANWÄLTE PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP1848727

ATNAHS PHARMA UK
Application Number
EP06701843A
Filing Date
Jan 24, 2006
Status
Revoked
Mar 11, 2022
Publication Date
Jun 17, 2015